METHYLPHENIDATE

methylphenidate hydrochloride 27 mg modified release tablet, 30

METHYLPHENIDATE (15169J)

Supply only until 01/12/2026
methylphenidate hydrochloride 27 mg modified release tablet, 30
15169J
Manner of administration:Oral
General Schedule
Authority Required

Restriction

Indication: Attention deficit hyperactivity disorder
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 30 # of repeats: 5 DPMQ: $174.54 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Atenza (Spain)